Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.

Tesla targets new highs as it grapples with April peak

A steady recovery since May for Tesla has been bolstered by the recent solid earnings update, putting the shares on course for more gains.

Tesla stock has continued to make gains since May, although it has continued to lag the S&P 500 and the Nasdaq 100 over the past six months.

Its latest set of earnings showed it recorded its eighth consecutive quarter of profits, although only the second in which net income was positive when the sale of regulatory credits is stripped out.

On the production front, it has pushed its semi-truck into next year, due to the requirement for the next generation battery. While it plans to launch its cybertruck later this year, it seems Ford will steal its thunder with the F-150, which is planned to enter the market before the Tesla model.

Operating margins rose for the quarter - to 11% - and the group has managed to clock up free cashflow in five of the past quarters. Growth stocks such as Amazon and Apple are loved for their remarkable powers of cash generation, and while Tesla is far from their giddying heights in this regard, signs of regular and solid cash generation are certainly welcome.

Investors will welcome the steady recovery in the stock price over the past few months, but it is the trader side of the equation that will be really delighted with the renewed upward move. Late June and early July saw the price push above the trendline resistance that had capped upside since early February.

Gains have reached the $763 zone that marked the high from early April, and if this can be breached to the upside then the February high just below $900 comes into view. Arguably the current bullish view would fade if the price drops below $660.

Related articles

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.